Reloxaliase

N/A

Report date: 2024/12/13 20:00:39

Base Information

Drug NameReloxaliase
Drug Alias Name瑞洛沙酶Oxalate decarboxylase - Allena PharmaceuticalsreloxaliaseALLN-177
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEnzyme replacements
TargetsUpdating
Therapy Area/IndicationsKidney CalculiNephrolithiasisHyperoxaluria, Primary +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllena Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllena Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsKidney CalculiNephrolithiasisHyperoxaluria, Primary +[4] 

Other Information

ATC CodeN/A
Related LinksN/A